TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.

Donald Hurley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.